BPC-157 does not have approval for any medical use in the United States, which means it has not met FDA standards for safety, effectiveness, and quality
20 g/g b.w
Its an autoimmune disease in which the immune system produces antibodies that attack the thyroid, causing fibrosis or scarring of the thyroid tissue ( Hashimotos disease is associated with a variety of symptoms, including weight gain, fatigue, hair loss, anemia, constipation, cold intolerance, joint pain, dry skin, mood changes, difficulty concentrating, and more ( In addition to medication, diet and lifestyle modification can help reduce thyroid damage and improve symptoms and overall quality of life in people with Hashimotos
Practical considerations and potential pitfalls Quality and sourcing The peptide market includes everything from pharmaceutical-grade products to questionable compounds of uncertain purity and potency
No findings imply clinical relevance, therapeutic application, physiological effects, or suitability for human or veterinary use